Opaleye Management Inc.

Position in ADCT — ADC Therapeutics SA

CIK 1595855 Boston, MA

Position in ADCT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$749,000

-$1,981,116 QoQ

Shares Held

700,000

+2.6% QoQ

Ownership

0.548%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#18

of 113 holders

Holding Since

Sep 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Opaleye Management Inc. holds $403,826,175 across 5 Drug Manufacturers - Specialty & Generic names. ADCT ranks #5 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LQDA	Liquidia Corp	2,447,500	$195,139,175
2	ETON	Eton Pharmaceuticals, Inc.	2,860,000	$103,532,000
3	HROW	Harrow, Inc.	2,400,000	$101,928,000
4	DERM	Journey Medical Corp	350,000	$2,478,000
5	ADCT	ADC Therapeutics SA This page	700,000	$749,000

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$749,000	700,000	+2.6%	Shares	Sole	2026-08-14
2025-09-30	$2,730,116	682,529	—	Shares	Sole	2025-11-14
No filing history on record for this holder in this stock.